Denis Thiolat

Denis Thiolat

UNVERIFIED PROFILE

Are you Denis Thiolat?   Register this Author

Register author
Denis Thiolat

Denis Thiolat

Publications by authors named "Denis Thiolat"

Are you Denis Thiolat?   Register this Author

15Publications

346Reads

44Profile Views

NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in Vitiligo.

J Invest Dermatol 2019 Dec 24. Epub 2019 Dec 24.

INSERM U1035, BMGIC, Immuno-dermatology, University of Bordeaux, Bordeaux, France; FHU ACRONIM, University of Bordeaux, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2019.11.013DOI Listing
December 2019

Inflammasome Activation Characterizes Lesional Skin of Folliculitis Decalvans.

Acta Derm Venereol 2018 Jun;98(6):570-575

Department of Dermatology and Pediatric Dermatology, National Centre for Rare Skin Disorders, Hôpital Saint-André, 1 rue Jean Burguet, FR-33075 Bordeaux Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-2924DOI Listing
June 2018

Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3.

J Invest Dermatol 2018 02 18;138(2):355-364. Epub 2017 Sep 18.

INSERM U1035, Biothérapies des Maladies Génétiques, Inflammatoires et Cancers (BMGIC), Immuno-dermatology ATIP-Avenir team, University of Bordeaux, Bordeaux, France; Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.08.038DOI Listing
February 2018

Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies are clinically and biologically distinct from vitiligo.

J Am Acad Dermatol 2017 May 13;76(5):863-870. Epub 2017 Jan 13.

Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1035, Biothérapies de Maladies Génétiques, Inflammatoires et Cancers (BMGIC), Immuno-dermatology ATIP-AVENIR, University of Bordeaux, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2016.10.044DOI Listing
May 2017

Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt kinase.

J Enzyme Inhib Med Chem 2008 Oct;23(5):648-58

PPF Médicaments-Parasitologie, UFR des Sciences Pharmaceutiques, Université Bordeaux 2, Bordeaux Cedex, France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/1475636080220544
Publisher Site
http://dx.doi.org/10.1080/14756360802205448DOI Listing
October 2008

Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis.

Arthritis Res Ther 2008 6;10(1):R19. Epub 2008 Feb 6.

Department of Immunology and Parasitology, EA3677, School of Pharmacy, Bordeaux 2 University, 146 rue Léo Saignat, 33076 Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar2372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374451PMC
July 2008

Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactions.

J Enzyme Inhib Med Chem 2007 Oct;22(5):541-9

EA 4138-Pharmacochimie, UFR des Sciences Pharmaceutiques, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14756360701425089DOI Listing
October 2007

Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.

Bioorg Med Chem 2007 Jan 1;15(1):194-210. Epub 2006 Oct 1.

EA 2962-Pharmacochimie, UFR des Sciences Pharmaceutiques, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2006.09.068DOI Listing
January 2007

Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators.

Biochem Pharmacol 2006 Nov 7;72(10):1304-10. Epub 2006 Sep 7.

Laboratory of Immunology and Parasitology, EA3677, Faculty of Pharmacy, Bordeaux 2 University, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2006.08.001DOI Listing
November 2006

Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages.

Antimicrob Agents Chemother 2004 Mar;48(3):924-9

Laboratoires d'Immunologie et de Parasitologie, E.A. 3677, Bases Thérapeutiques Anti-Infectieuses et Anti-Inflammatoires, Université Bordeaux II, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC353125PMC
http://dx.doi.org/10.1128/aac.48.3.924-929.2004DOI Listing
March 2004

Anti-leukemia activity of 7-hydroxy-2-substituted-methyl-5H-oxazolo[3,2-a]pyrimidin-5-one derivatives.

J Enzyme Inhib Med Chem 2002 Dec;17(6):391-6

EA 2962-Pharmacochimie, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1475636021000005668DOI Listing
December 2002

Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells.

Carcinogenesis 2002 Aug;23(8):1327-33

Bone Marrow Transplantation and Hematology Laboratories, CNRS UMR5540, EA 482 and GESNIT-EA 491, Victor Segalen Bordeaux-2 University, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/23.8.1327DOI Listing
August 2002